Parkinson's disease receiving r-metHuGDNF via continuous intraputaminal infusion. Methods. We generated apoE and FcRγ double-knockout (FcRγ/apoE-KO) mice, and subsequently introduced several kinds of human recombinant apoE genes. At 21 days after infection, the mice were sacrificed and histologically examined. Peritoneal macrophages were evaluated for their response to modified lipids.
Introduction
Lipoprotein glomerulopathy (LPG) is a recently identified renal disease [1] that was originally described in 1989 by Saito et al. and mainly affects people of Japanese and Chinese origin. LPG patients commonly show severe proteinuria and progression to renal failure. A histological characteristic of LPG is the deposition of a thrombuslike substance in markedly dilated glomerular capillaries; these substances positively stain for Sudan IV and oil red O. Moreover, patients with LPG have elevated concentrations of intermediate-density lipoprotein (IDL) and plasma apolipoprotein E (apoE) levels similar to those seen in type III dyslipidemia [2] .
In 1997, a novel apoE variant, apoE-Sendai (Arg145Pro), was identified in Japanese patients with LPG [3] . Since the identification of apoE-Sendai, various other apoE mutations have subsequently been discovered [4] [5] [6] [7] [8] [9] [10] [11] [12] . In murine studies, Ishigaki et al. [13] and our group [14] reported that the apoE-knockout (KO) mice that received virus-mediated transduction of apoE-Sendai developed the murine counterpart of LPG. Therefore, the dyslipidemia that resulted from the apoE variants was considered an important factor in LPG development. However, non-responders of renal lesions in apoE-Sendaitransfected mice [13] , healthy carriers with apoE variants in families of patients with LPG [2] and LPG patients with normal lipid profiles [15] suggest the involvement of other factors in the development of LPG.
In another murine experimental study published by Kanamaru et al. [16] , renal lesions specific to LPG were shown to develop in Fc receptor (FcR) gamma chain (FcRγ)-KO mice in which chronic graft-versus-host disease (cGVHD) had been induced. FcRs are expressed in the hematopoietic cell lineage and mediate phagocytosis and antibody-dependent cell cytotoxicity in the immune and resident cells of many tissues [17] . Two general immunoglobulin G (IgG) Fc receptor (FcγR) classes are known: the activating receptors and the inhibitory receptors, which transmit their signals via immunoreceptor tyrosine-based activation motif and immunoreceptor tyrosine-based inhibitory motif, respectively [18] . The activating FcγRs require an FcRγ homodimer for surface expression and signal transduction in the mouse system. In FcRγ-KO mice, the activating FcγRs (FcγRI and FcγRIII) are not expressed, but the inhibitory FcγR (FcγRIIb) is expressed and remains functional [19] . Kanamaru et al. [16] suggested that the absence of an activating inflammatory signal in cGVHD-induced FcRγ-KO mice might affect the development of LPG in chronic inflammatory kidneys through FcRs. Further, FcRγ deficiency was suggested to be another potential factor for LPG development. However, these researchers were unable to examine how FcRγ deficiency in their murine model played a role in lipid accumulation in LPG lesions in the combination with an apoE abnormality, since FcRγ-KO mice have no evident impairment on lipid metabolism.
In this study, we generated apoE and FcRγ doubleknockout (FcRγ/apoE-KO) mice by crossing apoE-KO mice with FcRγ-KO mice and subsequently introduced several kinds of human recombinant apoE genes using virus-mediated gene transfer. We then evaluated their renal histology, lipid profiles and macrophage function and elucidated the role of FcRγ in the pathogenesis of LPG in the presence of various expressed human apoE proteins.
Materials and methods

Experimental animals
ApoE-KO mice in the C57BL/6 background were obtained from Dr Oikawa, Nippon Medical School (Tokyo, Japan); FcRγ-KO mice in the C57BL/6 background were provided by Dr Takai, Institute of Development, Aging and Cancer, Tohoku University (Sendai, Japan). Male apoE-KO mice were crossed with female FcRγ-KO mice, and the progeny were repeatedly bred with one another to obtain a FcRγ/apoE-KO lineage. The apoE and FcRγ genotypes were determined by genomic PCR using specific primers [48] [49] [50] . Mice were bred and maintained at the Fukuoka University Animal Center under SPF conditions and protocols in accordance with the institutional guidelines for animal experiments at Fukuoka University. The mice had free access to a standard diet (CRF-1 ®, containing normal 5.7% fat and 0% cholesterol; Japan Chares River Ltd., Yokohama, Japan) and water.
Propagation, purification and administration of RAs
RAs containing the entire coding regions of the human apoE-Sendai, and the human apoE3 and LacZ gene were provided by Dr Ishigaki, Tohoku University School of Medicine (Sendai, Japan), and had been generated as described previously [13] . The RAs were propagated in 293 cells, purified by CsCl ultracentrifugation and stored in phosphate-buffered saline containing 10% (w/v) glycerol at −80°C. Each RA was injected into age-matched male mice (5 months of age) via the tail vein (2 × 10 9 plaque-forming units/mouse).
Evaluation of urine and serum samples
Spot urine was collected at each time point, and urinary protein concentrations and Cr levels were assessed. Urinary protein excretion was estimated from the urine protein/Cr ratio. Blood was collected from the retro-orbital venous plexus after 4 h of fasting at each time point. Serum TC, TG and UN levels were determined in individual mice at each time point by enzymatic assay kits (Wako Pure Chemical Co., Osaka, Japan). Serum human apoE levels were determined using an enzyme-linked immunodiffusion assay kit (Sekisui Medical Co., Tokyo, Japan). Furthermore, plasma lipoprotein profiles were analyzed by an online dual enzymatic method for simultaneous quantification of cholesterols and TGs by HPLC as previously described [51] .
Histological analysis
Kidneys were dissected 21 days after viral administration and examined by light microscopy, electron microscopy and immunohistochemistry. For light microscopy, the removed kidneys were fixed in Carnoy's solution, and paraffin-embedded sections were stained with PAS and AM. In addition, lipid staining was performed by a modified method described by Mochizuki et al. [20] as follows: the specimens were initially fixed in formalin and then post-fixed in a mixed solution of 2% OsO 4 and 10% potassium dichromate for lipid fixation; the samples were then dehydrated through an alcohol series and embedded in paraffin; the sections were then stained with oil red O by a standard procedure. This method allows a detailed observation of lipoprotein thrombi in glomerular capillaries, since the OsO 4 -fixed lipids remain in the specimens after alcohol dehydration. For electron microscopy, small blocks of kidney tissue were fixed with 2.5% glutaraldehyde and 2% paraformaldehyde, post-fixed with 1% OsO 4 , and embedded in Epon 812 by conventional methods. The sections were double-stained with uranyl acetate and lead citrate. For immunohistochemistry, 95% alcohol-fixed and paraffinembedded sections were incubated with anti-mouse CD68 antibody (HycultBiotech Inc., Uden, The Netherlands) at a concentration of 1 μgIgG/mL in PBS with 1% bovine serum albumin. Staining was performed using anti-mouse IgG-horseradish peroxidase-labeled polymer (DakoCytomation Inc., Carpinteria, USA). The numbers of anti-CD68 Ab-positive cells were calculated in 50 randomly selected glomeruli in each mouse.
Preparation of peritoneal macrophages
Mice were killed and exsanguinated 21 days after viral administration. The peritoneal cavities were rinsed with 5 mL of cold Hank's solution (HS; Sigma-Aldrich Inc., St. Louis, USA). Cells suspended in HS were washed by centrifugation and resuspended in RPMI1640 (HyClone Laboratories Inc., South Logan, USA) containing 20% fetal bovine serum (FBS). These collected peritoneal macrophages were cultured at a concentration of 2 × 10 6 cells/well and used for the ox-LDL uptake analysis and ELISA assay.
Ox-LDL uptake and ELISA assay of cultured macrophages
Ox-LDL was purchased from Biomedical Technologies Inc. (Stoughton, USA). After overnight incubation at 37°C, macrophages were cultured for 24 h at 37°C in the presence of ox-LDL (10 μg/mL) in RPMI1640-20% FBS. Cultured macrophages were stained with oil red O by a standard procedure. Afterwards, foam-cell formation was observed by light microscopy, and the numbers of cells changing into foam cells were determined and divided by the total number of glomeruli in five randomly selected sections in each mouse. Meanwhile, the supernatants were collected at each time point, and the concentrations of murine MCP-1 and RANTES were measured with commercial ELISA kits (R&D Systems Europe Ltd., Abingdon, UK).
Real-time quantitative PCR
Preparation of total RNA from kidney specimens, quantitative cDNA amplification, the reverse transcription reaction, TaqMan PCR and the detection of sequence-specific amplification were performed as previously described [41] . The transcription levels of the LDL-R gene (Ldlr) and SR genes (Scara3, Cd36, Cd68, Lox1, Scarf2 and Cxcl16) were assessed. Oligonucleotide primers and probes were designed using the Primer Express program (Applied Biosystems Japan) and synthesized;
and Actb (Mm00607839_s1). The transcription levels in all the samples were normalized to the amount of β-actin (Actb).
Statistical analysis
All data are presented as the mean ± SE. Statistical comparisons between two groups of parametric data were made using an unpaired t-test, while those between two groups of non-parametric data were determined using the Mann-Whitney U-test. For multiple comparisons, analysis of variance was performed with subsequent post hoc analysis according to Bonferroni. Kendall's rank correlation was used to assess the relationships between the number of CD68-positive cells/glomeruli and the percentage of lipoprotein thrombi-positive glomeruli. All statistical tests were done using SPSS version 18.0. A value of P < 0.05 was regarded as statistically significant.
Results
Plasma expression of apoE
Recombinant adenoviruses (RAs) containing human apoE-Sendai and apoE3 were injected into FcRγ/apoE-KO mice [designated FcRγ(−)/apoE(−;E-Sendai) and FcRγ(−)/apoE(−;E3) mice, respectively], and the plasma levels of human apoE at multiple time points were determined. A control RA containing a modified chicken β-galactosidase gene (referred to as LacZ) was also injected into FcRγ/apoE-KO and FcRγ-KO mice. These control mice were designated FcRγ(−)/apoE(−;LacZ) and FcRγ(−)/apoE(+;LacZ) mice, respectively. In the mice carrying the human apoE genes, the levels of plasma human apoE rapidly reached maximal levels of about 6-9 ng/μL at 4 days after infection and then declined rapidly to near baseline at 10-14 days after injection. No significant differences were observed in apoE levels between the FcRγ(−)/apoE(−;E-Sendai) and the FcRγ(−)/ apoE(−;E3) mice. Meanwhile, serum apoE was not detected in the FcRγ(−)/apoE(−;LacZ) mice ( Figure 1A) . Furthermore, no serum apoE was detected in the The data are shown as the mean (SE) for the FcRγ(−)/apoE(−;E-Sendai) (n = 11), FcRγ(−)/apoE(−;E3) (n = 10) and FcRγ(−)/apoE(−;LacZ) (n = 7) mice. As a control, the results for the FcRγ(−)/apoE(+;LacZ) mice (n = 7) are also shown.
FcRγ(−)/apoE(+;LacZ) mice, because of differences between human and murine apoE.
Injected apoE variants differentially affect the serum lipid profiles of FcRγ/apoE-KO mice Body weight, food intake, urinary protein/creatinine (Cr) ratios and serum levels of urea nitrogen (UN), total cholesterol (TC) and triglyceride (TG) were assessed at multiple time points. The urinary protein/Cr ratios and serum UN levels showed no significant difference among all the groups during the experiment (data not shown). On the other hand, serum TC levels in the FcRγ/apoE-KO mice were initially 7-fold higher than the baseline levels observed in the FcRγ-KO mice ( Figure 1B) . Serum TC levels in the FcRγ(−)/apoE(−;E3) mice rapidly decreased to a normal range after RA injection, and this marked decrease was sustained throughout the experimental period. The FcRγ(−)/apoE(−;E-Sendai) mice also showed a decrease in serum TC levels, but the effects were much less than those in the FcRγ(−)/apoE(−;E3) mice. Moreover, serum TC levels increased gradually over time following this initial decrease. Serum TC levels in the FcRγ(−)/ apoE(−;LacZ) and the FcRγ(−)/apoE(+;LacZ) mice remained stable during the experiment. In contrast to the pattern observed for the TC values, serum TG levels in the FcRγ(−)/apoE(−;E-Sendai) and the FcRγ(−)/apoE(−; E3) mice transiently increased after RA injection and then declined toward the baseline 2 weeks after injection ( Figure 1C) . The two other groups injected with LacZ showed no apparent changes in TG levels. Because body weight and food intake remained unchanged throughout the experimental period (data not shown), these alterations in serum TC and TG levels were dependent on the expression of apoE.
High-performance liquid chromatography (HPLC) analysis was carried out to determine in greater detail the effects of the expression of each injected apoE. Consistent with the reduction in TC levels, chylomicron (CM), very low-density lipoprotein (VLDL), IDL and LDL cholesterol levels were almost normalized in the FcRγ(−)/apoE (−;E3) mice ( Figure 1D) , with the reduction much less substantial in the FcRγ(−)/apoE(−;E-Sendai) mice. In terms of serum TG, extremely high levels of VLDL-and IDL-TG were seen in the FcRγ(−)/apoE(−;E3) and the FcRγ(−)/apoE(−;E-Sendai) mice after RA injection ( Figure 1E) , with the increase significantly steeper for the FcRγ(−)/apoE(−;E3) mice. These differences were especially prominent in the fractions containing the smaller VLDLs and the larger LDLs. The FcRγ(−)/apoE (−;LacZ) and FcRγ(−)/apoE(+;LacZ) mice showed similar lipoprotein profiles before and after RA injection.
FcRγ(−)/apoE(−;E3) mice displayed the most drastic LPG-like changes
Kidney samples taken from mice 3 weeks after RA injection were examined histologically. Lipoprotein-containing, thrombus-like substances in dilated vascular lumens, a feature mimicking human LPG, were observed under light microscope in FcRγ(−)/apoE(+;LacZ), FcRγ(−)/ apoE(−;E-Sendai) and FcRγ(−)/apoE(−;E3) samples visualized with periodic acid Schiff (PAS) (data not shown) and Azan-Mallory (AM) stain (Figure 2A, a-c) . These substances also stained with oil red O in osmium tetroxide (OsO 4 )-post-fixed specimens (Figure 2A, e-g ). Moreover, as revealed by electron microscopy, the bodies containing the substances possessed lamellar-like structures of various electron densities, as well as numerous, small lipid vacuoles (Figure 2A, i-k) . These were compatible with lipoprotein thrombi in patients with LPG. In contrast, these abnormalities were not detected in the FcRγ(−)/apoE(−;LacZ) mice (Figure 2A, panels d and h) . In a quantitative examination of renal sections stained for lipids, an average of 30.1 ± 9.3% of the glomeruli in the FcRγ(−)/apoE(−;E3) mice showed lipoprotein thrombi, whereas only 8.8 ± 4.4 and 2.4 ± 2.4% were positive in the FcRγ(−)/apoE(−;E-Sendai) and FcRγ(−)/apoE(−; LacZ) mice, respectively ( Figure 2B ).
The lack of FcRγ is related to the development of LPG in concert with expressed human apoEs
To confirm the influence of FcRγ deficiency in the development of LPG, we injected RAs containing the human apoE3 gene into the age-matched apoE-KO [referred to as FcRγ(+)/apoE(−;E3)] mice and compared the results with those for the FcRγ(−)/apoE(−;E3) mice. As a control, the FcRγ-KO mice with murine wild-type apoE were also infected with RAs containing the human apoE3 gene; these mice were designated as FcRγ(−)/apoE(+;E3) mice. In all the groups, the body weight and food intake were comparable throughout the experimental period (data not shown). Moreover, as seen for the FcRγ(−)/apoE(−;E3) mice, the FcRγ(+)/apoE(−;E3) mice also showed a rapid decrease in serum TC levels and a transient increase in serum TG levels after RA injection (data not shown). Thus, serum lipid profiles were not affected by the lack of FcRγ. In a histological examination, enlarged capillary lumina with lipoprotein thrombi were seen in FcRγ(+)/apoE(−;E3) samples, but the frequency at which glomeruli with lipoprotein thrombi were observed was only 3.8 ± 2.7% ( Figure 3A) . Meanwhile, no LPG lesions were present in the FcRγ(−)/apoE(+;E3) mice.
Macrophages rarely infiltrated into the glomeruli of FcRγ (−)/apoE(−;E3) mice compared with FcRγ(+)/apoE (−;E3) mice
Macrophage infiltration of glomeruli was examined by immunohistological examination using anti-mouse CD68 Ab. Cells positive for CD68 had markedly infiltrated the glomeruli in the FcRγ(+)/apoE(−;E3) mice, and often showed foam-cell formation. In contrast, the macrophage infiltration of glomeruli and foam-cell formation were rarely observed in the FcRγ(−)/apoE(−;E3) mice ( Figure 3B The macrophage response to modified LDL was suppressed in FcRγ(−)/apoE(−;E3) mice
We then examined the macrophage response to oxidized LDL (ox-LDL), which is a representative modified LDL. Number-matched peritoneal macrophages collected from the FcRγ(−)/apoE(−;E3) and FcRγ(+)/apoE(−;E3) mice were cultured with ox-LDL (10 μg/mL) for 24 h. Afterwards, the macrophages were stained with oil red O. Ox-LDL that had been taken up was observed as oil red Opositive substances in the macrophages. The ratios of cells positive for oil red O were 28.9 ± 5.2% for the FcRγ(−)/apoE(−;E3) samples and 79.3 ± 1.6% for the FcRγ(+)/apoE(−;E3) samples. The uptake of ox-LDL by the peritoneal macrophages was significantly reduced for FcRγ(−)/apoE(−;E3) relative to that forFcRγ(+)/apoE (−;E3)( Figure 4A and B) . In the supernatant with the peritoneal macrophages, the expression of monocyte chemotactic protein-1 (MCP-1) and regulated upon activation, normal T-cell expressed and secreted (RANTES) was evaluated by enzyme-linked immunosorbent assay (ELISA) at each time point. The concentrations of MCP-1 and RANTES in the FcRγ(−)/apoE(−;E3) samples were significantly reduced after administration of ox-LDL compared with those in the FcRγ(+)/apoE(−;E3) samples ( Figure 4C and D) .
The transcript levels of the LDL receptor gene (Ldlr) in the kidney were reduced in FcRγ(−)/apoE(−;E3) mice relative to those in FcRγ(+)/apoE(−;E3) mice
To obtain a clear understanding of the mechanism for the reduced lipid uptake in the macrophages, mRNA transcripts of the LDL receptor (LDL-R), i.e. Ldlr, and major scavenger receptors (SRs), i.e. Scara3, Cd36, Lox1, Scarf2 and Cxcl16, were evaluated by quantitative realtime polymerase chain reaction (PCR) in the kidney. No significant differences in the levels of mRNA transcripts for these SRs (data not shown) were observed. However, Ldlr transcripts were significantly reduced in the FcRγ(−)/apoE(−;E3) mice compared with those in the FcRγ(+)/apoE(−;E3) mice ( Figure 4E ).
Discussion
LPG is a disease characterized by the deposition of lipoprotein thrombi in markedly dilated glomerular capillaries. Moreover, apoE-Sendai and several other apoE mutations have often been found in patients with LPG [4] [5] [6] [7] [8] [9] [10] [11] [12] , so that apoE variants are considered to be an important factor in LPG development. However, healthy carriers of apoE variants in families of patients with LPG have not been rare [2] . Further, Ishigaki et al. [13] described a murine LPG model in which mutated human apoE had induced LPG in apoE-KO mice and found that only some of the mice were responders of renal lesions.
On the other hand, Kanamaru et al. [16] indicated that FcRγ deficiency was involved in the development of LPG in mice with cGVHD. However, this group could not explain in particular the apoE abnormalities observed in human LPG because FcRγ-KO mice have normal lipid profiles. In the present study, to examine the mechanism by which the combination of an apoE mutation and FcRγ deficiency affects the development of LPG, we generated FcRγ/apoE-KO mice and subsequently introduced several kinds of human recombinant apoE genes using virusmediated gene transfer.
In particular, we performed lipid fixation by OsO 4 [20] for the kidney specimens. Lipoprotein thrombi are seen as vacuolar or empty spaces by light microscopy. This manifestation has hindered the detailed observation of the glomerular features, and evaluations using traditional paraffin-embedded sections pose the risk of minor lesions with lipoprotein thrombi being overlooked with light microscopy. This method allowed us to observe lipid deposition in the murine glomeruli in detail.
In the current study, we observed that FcRγ(−)/apoE (+;LZ) mice, which expressed the murine wild-type apoE, displayed a few LPG-like lipoprotein thrombi (Figure 2 ), indicating that LPG barely develops under conditions of FcRγ deficiency when wild-type apoE is present. On the other hand, LPG lesions were present under conditions with human recombinant apoEs, as shown with the FcRγ(−)/apoE(−;E-Sendai) and FcRγ(−)/apoE(−;E3) mice (Figure 2 ). Against our expectations, FcRγ(−)/apoE(−;E3) mice, which carried the wild-type human apoE, showed more drastic LPGlike changes than FcRγ(−)/apoE(−;E-Sendai) mice, although apoE-Sendai has been reported to be one of most important apoE variants identified in patients with LPG ( Figure 2B ) [2, 13, 21] .
The structural differences between human and murine wild-type apoE have been reported [22] . In addition to human apoE-Sendai, human apoE3 may also act as an abnormal apoE in mice and lead to LPG in a murine model, although apoE3 is the wild-type version of the human apoE. In addition, an alteration in the lipoprotein composition may be related to it. Xenogeneic apoE injection induced severe hypertriglyceridemia [13] , though the mechanism was unknown. In this study, the serum TG levels were elevated after apoE injection and were substantially higher in the FcRγ(−)/apoE(−;E3) mice than in the FcRγ(−)/apoE(−;E-Sendai) mice. These results suggest that the overloading of TG-rich lipoproteins may play a more important role in the development of LPG than hypercholesterolemia. This interpretation is consistent with previous reports that abnormal TG metabolism may have a pathogenic role in the peculiar glomerular lesions of human LPG [23] , and that TG-lowering therapies, such as the use of fibrates, are more effective than cholesterol-lowing therapies, such as the use of human menopausal gonadotrophin-CoA inhibitors in patients with LPG [24] [25] [26] . Furthermore, the increased TGs in the FcRγ(−)/apoE(−;E3) and FcRγ(−)/apoE(−;E-Sendai) mice were primarily distributed within the smaller VLDLs and larger LDLs ( Figure 1E ). These fractions are elevated in patients with type III hyperlipoproteinemia [27] , and the levels in these groups are comparable with those seen in LPG patients [21] .
In this study, we also observed that the frequency of lipoprotein thrombi in the FcRγ(−)/apoE(−;E3) mice was significantly greater than that in the FcRγ(+)/apoE(−;E3) mice ( Figure 3A) , despite the similar lipid profiles. These results clearly indicate that FcRγ deficiency leads to worsened LPG under conditions of human apoE3 expression. Moreover, we noticed fewer infiltrated macrophages and foam-cell changes in the glomeruli of the FcRγ(−)/ apoE(−;E3) mice than in those of the FcRγ(+)/apoE(−;E3) mice ( Figure 3B and C) . These findings were consistent with previous reports that foam cells are rarely observed in the glomeruli of patients with LPG, despite their hyperlipidemia [2, 21] . In contrast, renal lipidosis, which is induced by type III hyperlipidemia, is characterized by severe glomerulosclerosis with a large number of foam cells [28, 29] . Analogous to the lesions for atherosclerosis [30] [31] [32] [33] , the importance of macrophages with SRs has been suggested to be an aggravating factor [34, 35] . These findings, which distinguished LPG from renal lipidosis, suggest that the lack of macrophage infiltration into glomeruli is a key observation elucidating the pathogenesis of LPG. Therefore, we hypothesized that the macrophage impairment resulting from FcRγ deficiency prompts lipoprotein thrombi to be deposited in the glomerular capillaries, in the current murine model.
To examine this hypothesis, we collected peritoneal macrophages from FcRγ(+)/apoE(−;E3) and FcRγ(−)/ apoE(−;E3) mice and examined lipid uptake and chemokine secretion after culturing the macrophages with excess ox-LDL, a representative modified LDL. The uptake of ox-LDL in FcRγ(−)/apoE(−;E3) macrophages was impaired relative to that in FcRγ(+)/apoE(−;E3) macrophages. Moreover, the secretion of MCP-1 and RANTES in the FcRγ(−)/apoE(−;E3) macrophages was also significantly reduced (Figure 4C and D) . These results indicate that the lack of FcRγ causes an impairment in the macrophage response to modified lipids.
Macrophages possess several SRs [36, 37] , which are involved in phagocytosis and are defined by their ability to bind modified forms of LDL [38] . Moreover, FcγR has been implicated in the up-regulation of SRs [39, 40] . Our group previously described a drastic decline in the mRNA expression of Cd36 in cGVHD-induced FcRγ-KO mice that had developed LPG [41] . However, an analysis of the mRNA expression of major SRs showed no significant differences between FcRγ(−)/apoE(−;E3) and FcRγ(+)/ apoE(−;E3) mice. On the other hand, LDL-R has been implicated in the formation of foam cells and in the uptake of LDL-containing immune complexes through FcγR [36, 42, 43] . In this study, the Ldlr were reduced in the kidneys of the FcRγ(−)/apoE(−;E3) mice, and the downregulation of LDL-R through FcγR may be one of the mechanisms in the impairment of macrophage function in the uptake of modified lipids. Moreover, FcγR activation triggers the production of cytokines, proteolytic enzymes and reactive oxygen intermediates [40, 42, 44] , and FcRγ is also known to be one of the receptors on macrophages involved in lipid metabolism [45] [46] [47] . In particular, FcγRI and FcγRII are involved in the uptake of modified LDL [45, 47] . Accordingly, the deficiency of FcRγI may contribute directly to the impairment of lipid uptake into macrophages in the current model. These macrophage impairments derived from FcRγ deficiency are insufficient for the development of LPG, since lipoprotein thrombi are rarely observed in FcRγ(−)/ apoE(+;LZ) and FcRγ(−)/apoE(+;E3) mice, which express normal murine apoE. However, under conditions with xenogeneic apoE, especially human apoE3, the FcRγ(−)/apoE(−;E3) mice developed severe LPG. These results indicate that impaired macrophages are unable to clear abnormal lipoproteins containing substantial amounts of TGs, causing excessive lipid deposits in tissues and thereby resulting in lipoprotein thrombi. Therefore, macrophage dysfunction may cause the development of LPG, though an increased function in macrophages has been regarded as an aggravating factor for renal lipidosis and atherosclerosis [34, 35] .
In conclusion, our results suggested that the impairment of macrophage function resulting from FcRγ deficiency plays a principal role in the development of LPG in concert with apoE abnormalities. Unfortunately, macrophage functions have not been examined in previously reported cases of LPG. An accumulation of more cases of LPG and research into macrophage function in these cases may facilitate the elucidation of its pathogenesis, as well as the evidence-based development of new therapies for LPG.
